Not applicableUnknownNCT05389007What this trial is testing.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)Who this might be right forThrombotic Thrombocytopenic Purpura Johannes Gutenberg University Mainz 156
Not applicableStudy completedNCT05876221What this trial is testingPlatelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic PurpuraWho this might be right forAcquired Thrombotic Thrombocytopenic Purpura University of Cologne 223
Not applicableLooking for participantsNCT07513948What this trial is testingDaratumumab in Immune-mediated Thrombotic Thrombocytopenic PurpuraWho this might be right forThrombotic Thrombocytopenic Purpura, Acquired Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 40
Testing effectiveness (Phase 2)UnknownNCT04021173What this trial is testingA Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)Who this might be right forAcquired Thrombotic Thrombocytopenic Purpura Lee's Pharmaceutical Limited 74
Testing effectiveness (Phase 2)Study completedNCT00907751What this trial is testingRituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic PurpuraWho this might be right forThrombotic Thrombocytopenic Purpura Assistance Publique - Hôpitaux de Paris 12
Not applicableActive Not RecruitingNCT05046717What this trial is testingImprovement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic PurpuraWho this might be right forAcquired Thrombotic Thrombocytopenic Purpura Fundación Española de Hematología y Hemoterapía 500
Testing effectiveness (Phase 2)Study completedNCT01151423What this trial is testingStudy to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)Who this might be right forAcquired Thrombotic Thrombocytopenic Purpura Ablynx, a Sanofi company 75
Not applicableStudy completedNCT01931644What this trial is testingAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsWho this might be right forAll Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more Sanguine Biosciences 17,667
Not applicableStudy completedNCT04845113What this trial is testingIdiopathic Purpura Fulminans Associated With Anti-PS Antibodies in ChildrenWho this might be right forIdiopathic Purpura University Hospital, Montpellier 200
Testing effectiveness (Phase 2)Looking for participantsNCT06794008What this trial is testingBCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more Peking University People's Hospital 50
Not applicableLooking for participantsNCT06727669What this trial is testingLongitudinal Cohort of Thrombosis and Hemostasis DiseasesWho this might be right forImmune ThrombocytopeniaThrombotic Thrombocytopenic PurpuraHemophilia A, Acquired+13 more Peking University People's Hospital 3,000
Post-approval studies (Phase 4)UnknownNCT05135442What this trial is testingEfficacy and Safety of Bortezomib as First-line Treatment of Acquired TTPWho this might be right forThrombotic Thrombocytopenic Purpura, Acquired Peking Union Medical College Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT05568147What this trial is testingAspirin for Prophylaxis of TTPWho this might be right forThrombotic Thrombocytopenic Purpura The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT03922308What this trial is testingStudy of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)Who this might be right forAcquired Thrombotic Thrombocytopenic Purpura (aTTP) Shire 28
Not applicableEnrolling By InvitationNCT02422875What this trial is testingComparative Autoantibody and Immunologic Cell Marker StudyWho this might be right forAutoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases Emory University 2,500
Testing effectiveness (Phase 2)Ended earlyNCT04720261What this trial is testingEfficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTPWho this might be right forThrombotic Thrombocytopenic Purpura, Acquired University Hospital, Rouen 58
Large-scale testing (Phase 3)Study completedNCT02553317What this trial is testingPhase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic PurpuraWho this might be right forAcquired Thrombotic Thrombocytopenic Purpura Ablynx, a Sanofi company 145
Testing effectiveness (Phase 2)Study completedNCT01554514What this trial is testingLow Dose Rituximab in Thrombotic Thrombocytopenic PurpuraWho this might be right forThrombotic Thrombocytopenic Purpura Washington University School of Medicine 19
Not applicableUnknownNCT05262881What this trial is testingA Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)Who this might be right forThrombotic Thrombocytopenic Purpura, Acquired Catholic University of the Sacred Heart 50
Not applicableActive Not RecruitingNCT04985318What this trial is testingRetrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTPWho this might be right forAcquired Thrombotic Thrombocytopenic Purpura University of Cologne 350